News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
849,852 Results
Type
Article (77771)
Company Profile (714)
Press Release (771341)
Multimedia
Podcasts (211)
Webinars (34)
Section
Business (228861)
Career Advice (3804)
Deals (39414)
Drug Delivery (163)
Drug Development (89869)
Employer Resources (206)
FDA (18223)
Job Trends (17241)
News (390186)
Policy (39062)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3033)
Academic (2)
Accelerated approval (45)
Adcomms (37)
Allergies (174)
Alliances (56419)
ALS (207)
Alzheimer's disease (1885)
Antibody-drug conjugate (ADC) (417)
Approvals (18455)
Artificial intelligence (700)
Autoimmune disease (249)
Automation (53)
Bankruptcy (404)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (219)
Biotechnology (446)
Bladder cancer (185)
Brain cancer (73)
Breast cancer (727)
Cancer (5650)
Cardiovascular disease (502)
Career advice (3267)
Career pathing (46)
CAR-T (331)
CDC (71)
Celiac Disease (2)
Cell therapy (901)
Cervical cancer (43)
Clinical research (76588)
Collaboration (2086)
Company closure (7)
Compensation (1314)
Complete response letters (91)
COVID-19 (3012)
CRISPR (110)
C-suite (1055)
Cystic fibrosis (160)
Data (7253)
Decentralized trials (3)
Denatured (80)
Depression (176)
Dermatology (59)
Diabetes (591)
Diagnostics (7403)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (345)
Drug pricing (237)
Drug shortages (37)
Duchenne muscular dystrophy (286)
Earnings (98762)
Editorial (71)
Employer branding (25)
Employer resources (174)
Events (135502)
Executive appointments (1111)
FDA (21790)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1732)
Gene editing (238)
Generative AI (72)
Gene therapy (749)
GLP-1 (1204)
Government (5472)
Grass and pollen (8)
Guidances (400)
Healthcare (20994)
HIV (80)
Huntington's disease (58)
IgA nephropathy (96)
Immunology and inflammation (327)
Immuno-oncology (92)
Indications (158)
Infectious disease (3357)
Inflammatory bowel disease (223)
Inflation Reduction Act (17)
Influenza (138)
Intellectual property (282)
Interviews (746)
IPO (17869)
IRA (61)
Job creations (4991)
Job search strategy (2636)
JPM (73)
Kidney cancer (19)
Labor market (104)
Layoffs (664)
Leadership (45)
Legal (9980)
Liver cancer (106)
Longevity (29)
Lung cancer (758)
Lymphoma (417)
Machine learning (54)
Management (66)
Manufacturing (1006)
MASH (194)
Medical device (15124)
Medtech (15207)
Mergers & acquisitions (22718)
Metabolic disorders (1589)
mRNA (216)
Multiple sclerosis (182)
NASH (24)
Neurodegenerative disease (436)
Neuropsychiatric disorders (117)
Neuroscience (3412)
Neurotech (1)
NextGen: Class of 2026 (7664)
Non-profit (5131)
Now hiring (74)
Obesity (777)
Opinion (355)
Ovarian cancer (190)
Pain (248)
Pancreatic cancer (268)
Parkinson's disease (363)
Partnered (39)
Patents (581)
Patient recruitment (620)
Peanut (65)
People (66272)
Pharmaceutical (127)
Pharmacy benefit managers (36)
Phase 1 (23683)
Phase 2 (33382)
Phase 3 (25159)
Pipeline (7322)
Policy (369)
Postmarket research (3282)
Preclinical (10450)
Press Release (72)
Prostate cancer (290)
Psychedelics (61)
Radiopharmaceuticals (330)
Rare diseases (1116)
Real estate (7218)
Recruiting (81)
Regulatory (28940)
Reports (73)
Research institute (2750)
Resumes & cover letters (593)
Rett syndrome (33)
RNA editing (22)
RSV (95)
Schizophrenia (178)
Series A (292)
Series B (214)
Service/supplier (27)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (185)
Sponsored (52)
Startups (4263)
State (2)
Stomach cancer (21)
Supply chain (129)
Tariffs (102)
The Weekly (128)
Vaccines (1228)
Venture capital (111)
Weight loss (530)
Women's health (115)
Worklife (23)
Date
Today (12)
Last 7 days (679)
Last 30 days (2789)
Last 365 days (32357)
2026 (8624)
2025 (32665)
2024 (37905)
2023 (42566)
2022 (53928)
2021 (58722)
2020 (57665)
2019 (51315)
2018 (39097)
2017 (36869)
2016 (37816)
2015 (43847)
2014 (38588)
2013 (34725)
2012 (36582)
2011 (36632)
2010 (36178)
Location
Africa (1220)
Alabama (99)
Alaska (7)
Arizona (351)
Arkansas (15)
Asia (50309)
Australia (8630)
California (12775)
Canada (3604)
China (1333)
Colorado (549)
Connecticut (554)
Delaware (383)
Europe (114912)
Florida (1905)
Georgia (418)
Hawaii (4)
Idaho (68)
Illinois (1064)
India (88)
Indiana (596)
Iowa (24)
Japan (506)
Kansas (137)
Kentucky (50)
Louisiana (44)
Maine (85)
Maryland (1575)
Massachusetts (9354)
Michigan (386)
Minnesota (724)
Mississippi (7)
Missouri (154)
Montana (37)
Nebraska (30)
Nevada (142)
New Hampshire (90)
New Jersey (3445)
New Mexico (33)
New York (3382)
North Carolina (1733)
North Dakota (10)
Northern California (6226)
Ohio (393)
Oklahoma (25)
Oregon (52)
Pennsylvania (2554)
Puerto Rico (27)
Rhode Island (53)
South America (1589)
South Carolina (78)
South Dakota (1)
Southern California (4985)
Tennessee (205)
Texas (2036)
United States (45900)
Utah (385)
Vermont (1)
Virginia (325)
Washington D.C. (88)
Washington State (1051)
West Virginia (4)
Wisconsin (142)
Wyoming (2)
849,852 Results for "apax partners and co".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
Pfizer ‘Confident’ in Valneva-Partnered Lyme Vaccine Despite Missed Primary Endpoint
The multivalent candidate, being developed by Pfizer and French partner Valneva under a 2020 pact, generated higher than 73% efficacy against the tick-borne disease in a Phase 3 trial—but failed to hit a predetermined confidence interval.
March 23, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Laigo Bio completes final close of oversubscribed seed financing of €17 million co-led by Biovance Capital and Kurma Partners to advance oncology and auto-immunity programs
March 23, 2026
·
4 min read
Press Releases
Model Medicines to Present Evidence of First Direct-Acting Antiviral Potent Against HCV, HBV, HDV, and Co-Infections at CROI 2026
Over 300 million patients are infected with HCV, HBV, HDV, and their co-infections. MDL-001 is the first oral small molecule to demonstrate potent, direct-acting antiviral activity across all three viruses and their co-infections.
February 18, 2026
·
1 min read
Press Releases
Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies
March 13, 2026
·
4 min read
Press Releases
YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform
February 25, 2026
·
5 min read
Press Releases
Takara Bio USA and Hamilton Company Partner to Automate NGS Library Preparation
March 30, 2026
·
3 min read
Press Releases
Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia
March 20, 2026
·
5 min read
Press Releases
STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs
February 2, 2026
·
3 min read
Press Releases
Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements
March 10, 2026
·
2 min read
Press Releases
Viz.ai Partners with Alnylam Pharmaceuticals to Advance Earlier Identification and Care Coordination in Cardiac Amyloidosis
March 24, 2026
·
3 min read
1 of 84,986
Next
